Jump to content

PubMed RSS Feed - - Quality of Health Care of Rosacea in Germany from the Patient's Perspective: Results of the National Health Care Study RosaReal 2009.


rss

Recommended Posts

Quality of Health Care of Rosacea in Germany from the Patient's Perspective: Results of the National Health Care Study RosaReal 2009.

Dermatology. 2011 Sep 5;

Authors: Langenbruch AK, Beket E, Augustin M

Abstract
Objectives: To obtain reliable data on quality of care of rosacea and to compare care indicators with those found in atopic dermatitis and psoriasis. Patients and Methods: In this cross-sectional study, clinical history, health-related quality of life (HrQoL), medication and treatment benefit of patients with rosacea were assessed by standardized questionnaires. Data were compared to patients with atopic dermatitis and psoriasis. Results: Almost all 475 participants (96.4%) had received topical therapy. 24% had used cortisone ointments. The mean Dermatology Life Quality Index (DLQI) was 4.3 ± 4.6 (atopic dermatitis: 8.5 ± 6.0, psoriasis: 6.7 ± 6.2). The Patient Benefit Index (patient-defined therapeutic benefit) was 1.9 ± 1.2 (psoriasis: 2.3 ± 1.1, atopic dermatitis: 2.1 ± 1.1). Conclusions: Only a small proportion of the rosacea patients had substantial impairments in HrQoL. Overall, their burden appears to be lower than in patients with atopic dermatitis or psoriasis. However, the lower therapeutic benefit and the high proportion of topical steroid use indicate a need for optimized therapy.

PMID: 21893958 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=21893958&dopt=Abstract = URL to article

Link to comment
Share on other sites

  • Root Admin

This study concluded:

"Only a small proportion of the rosacea patients had substantial impairments in HrQoL. Overall, their burden appears to be lower than in patients with atopic dermatitis or psoriasis."

So I guess we can be happy that we have rosacea rather than atopic dermatitis or psoriasis. I think the RRDi should conduct a study following the same standardized questionnaires to compare data with the German study. What do you think? I wonder how much such a study costs? What do you think?

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...